MOLN vs TWIN Comparison

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Twin Disc Inc designs, manufactures and sells marine and heavy-duty off highway power transmission equipment. Its products are marine transmissions, azimuth drives, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, controls systems, and braking systems. The company sells its products to customers in the pleasure craft, commercial, and military marine markets, as well as in the energy and natural resources, government, military, and industrial markets. It has two reportable segments: manufacturing and distribution. It derives the maximum revenue from the manufacturing segment. Geographically, it operates in United States, Netherlands, Finland, China, Australia, Italy and Others.